The Coronavirus disease 19 (COVID-19) outbreak has been recognized as a global threat to public health. It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and no effective therapies currently exist against this novel viral agent. Along with extensive public health measures, an unprecedented global effort in identifying effective drugs for the treatment is being implemented. Potential drug targets are emerging as the result of a fast-evolving understanding of SARS-CoV-2 virology, host response to the infection, and clinical course of the disease. This brief review focuses on the latest and most promising pharmacological treatments against COVID-19 currently under investigation and discuss their potential use based on either documented efficacy in similar viral infections, or their activity against inflammatory syndromes. Ongoing clinical trials are also emphasized.

Treatments for COVID-19: emerging drugs against the coronavirus / Potì, Francesco; Pozzoli, Cristina; Adami, Maristella; Poli, Enzo; Costa, Lucio G. - In: ACTA BIOMEDICA. - ISSN 2531-6745. - 91:2(2020), p. 118-136. [10.23750/abm.v91i2.9639]

Treatments for COVID-19: emerging drugs against the coronavirus

Potì, Francesco
;
Pozzoli, Cristina;Adami, Maristella;Poli, Enzo;Costa, Lucio G
2020

Abstract

The Coronavirus disease 19 (COVID-19) outbreak has been recognized as a global threat to public health. It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and no effective therapies currently exist against this novel viral agent. Along with extensive public health measures, an unprecedented global effort in identifying effective drugs for the treatment is being implemented. Potential drug targets are emerging as the result of a fast-evolving understanding of SARS-CoV-2 virology, host response to the infection, and clinical course of the disease. This brief review focuses on the latest and most promising pharmacological treatments against COVID-19 currently under investigation and discuss their potential use based on either documented efficacy in similar viral infections, or their activity against inflammatory syndromes. Ongoing clinical trials are also emphasized.
Treatments for COVID-19: emerging drugs against the coronavirus / Potì, Francesco; Pozzoli, Cristina; Adami, Maristella; Poli, Enzo; Costa, Lucio G. - In: ACTA BIOMEDICA. - ISSN 2531-6745. - 91:2(2020), p. 118-136. [10.23750/abm.v91i2.9639]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11381/2876491
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 16
  • ???jsp.display-item.citation.isi??? ND
social impact